Network pharmacology study on the mechanism of berberine in Alzheimer’s disease model
Abstract Research indicated that berberine (BBR) plays a protective role in modulating Alzheimer’s disease (AD). This study aimed to explore the target genes of BBR associated with AD therapy using a network pharmacology study. Through network pharmacology analysis, two main potential target genes,...
Saved in:
Main Authors: | Yaoyi Zhang, Shuai Lv, Pinyuan Huang, Lingmin Xiao, Nan Lin, En Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | npj Science of Food |
Online Access: | https://doi.org/10.1038/s41538-025-00378-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Network pharmacology and experimental verification to investigate the mechanism of isoliquiritigenin for the treatment of Alzheimer’s disease
by: Waimao Gao, et al.
Published: (2025-02-01) -
Berberine-induced browning and energy metabolism: mechanisms and implications
by: Aslıhan Alpaslan Ağaçdiken, et al.
Published: (2025-02-01) -
Network pharmacology and molecular analysis of mechanisms underlying the therapeutic effects of Rhubarb in treating atherosclerosis and abdominal aortic aneurysm
by: Huilin Xu, et al.
Published: (2025-02-01) -
Danggui-Shaoyao-San Can Ameliorate Alzheimer’s Disease by Inhibiting Hippocampal Neuron Apoptosis: Findings from Serum Pharmacology
by: Zhang KX, et al.
Published: (2025-02-01) -
Therapeutic effect of dihydroartemisinin on Alzheimer’s disease model mice with senile macular degeneration
by: Gao Han, et al.
Published: (2025-02-01)